Mayne Pharma Generic Haloette Receives Approval in the U.S.
Teva Pharms USA`s Generic Etonogestrel; Ethinyl Estradiol Receives Approval In US
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA), today announced the availability ofa generic version of NuvaRing®1 (etonogestrel and ethinyl estradiol vaginal ring), 0.120 mg/0.015 mg per day, in the U.S. Teva’s AB-rated and bioequivalent etonogestrel and ethinyl estradiol vaginal ring, is an estrogen/progestin combination hormonal contraceptive (CHC) indicated for use by women to prevent pregnancy.
A popular birth control implant that has long been advocated for use in Canada has now been approved by Health Canada, according to the agency.
Nexplanon (etonogestrel) contraceptive implants: new insertion site to reduce rare risk of neurovascular injury and implant migration
Mayne, Mithra bring novel oral contraception in the US
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)